PF-4856884

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePF-4856884
Drug Alias NameCVX-060CovX 060PF-04856884
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAngiopoietin-2 inhibitors
TargetsAngiopoietin-2
Therapy Area/IndicationsSolid tumoursCarcinoma, Renal CellCarcinoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCovx PharmaceuticalsPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Renal CellCarcinoma +[5] 

Other Information

ATC CodeN/A
Related LinksN/A